Standard Family Office LLC Eli Lilly & CO Transaction History

Standard Family Office LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $180,556 - $205,762	609 New	609 $197,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $146,602 - $181,934	-652 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $916,537 - $1.13 Million	-4,136 Reduced 86.38%	652 $151,000
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $117,718 - $152,268	652 Added 15.76%	4,788 $1.1 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $107,136 - $138,693	-652 Reduced 13.62%	4,136 $773,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $624,642 - $826,552	4,788 New	4,788 $808,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.